Skip to main content
Clinical Trials/CTRI/2023/04/051277
CTRI/2023/04/051277
Not yet recruiting
Phase 2

A Comparative assessment of Effectiveness of Triphala Gritapana and Viddhakarma with Antioxidants Therapy in Vataja Timira (Age Related Macular Degeneration Dry type )

Dr Vaishnavi Yashwant Jugdhar0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: H353- Degeneration of macula and posterior pole
Sponsor
Dr Vaishnavi Yashwant Jugdhar
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Vaishnavi Yashwant Jugdhar

Eligibility Criteria

Inclusion Criteria

  • 1\. Hazy blurred and distorted central vision ,Decreased visual acuity and pinhole vision
  • 2\. Dull Macular reflex and Drusen Macular reflex in fundoscopic examination.
  • 3\. ARMD with immature Cataract , with operated Cataract,or with no Cataract changes

Exclusion Criteria

  • 1\. All Retinal diseases involving Macula like CSR and CME
  • 2\. Uncontrolled DM and HTN
  • 3\. Psychiatric disorders
  • 4\. Corneal lenticular or Vitreous opacities
  • 5\. HIV and HbsAg pts.
  • 6\. pts with cataract grading NS2 /NS3
  • 7\. Those who are ayogya for siravedha and ghrutapana

Outcomes

Primary Outcomes

Not specified

Similar Trials